ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,460Medicare Part D Prescriptions Filled, Including Refills

Rank: 105 out of 890

$9,419 Total Retail Price of All Prescriptions

Rank: 872 out of 890

195 Patients Receiving at Least One Drug in Part D
86%Patients 65 Years and Older
100% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Louisiana
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 195 patients filled at least one prescription for a schedule two drug, compared to an average of 2%.

Schedule Three
Controlled Substances

14% of this provider’s 195 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

1% of this provider’s 12,845 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$1 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

74 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Louisiana
AMLODIPINE BESYLATE 640 532 1 1
SIMVASTATIN 588 508 2 5
ASPIRIN 501 460 10 3 259
NAMENDA 473 455 4 36
LISINOPRIL 445 369 5 4
FUROSEMIDE 436 400 6 7
VITAMIN D2 406 371 7 225
OMEPRAZOLE 368 327 8 8
DONEPEZIL HCL 357 339 9 30
CITALOPRAM HBR 323 254 10 20
DOK 303 280 11 302
OYSTER SHELL CALCIUM W-VIT D 298 295 12 303
ASPIR-LOW 250 209 10 13 318
METOPROLOL TARTRATE 244 214 14 15
MAPAP ARTHRITIS PAIN 231 219 10 15 324
GABAPENTIN 226 157 16 12
METFORMIN HCL 207 184 17 6
WARFARIN SODIUM 185 173 18 24
PRAVASTATIN SODIUM 161 143 19 10
CARVEDILOL 151 119 20 22
HYDROCHLOROTHIAZIDE 130 120 21 9
DIOVAN 128 128 22 33
METOPROLOL SUCCINATE 128 124 22 17
TRAVATAN Z 126 126 24 310
KLOR-CON M20 124 124 25 72
LEVOTHYROXINE SODIUM 112 98 26 2
ADVAIR DISKUS 112 112 26 52
LISINOPRIL-HYDROCHLOROTHIAZIDE 107 105 28 21
ALENDRONATE SODIUM 107 106 28 38
POTASSIUM CHLORIDE 106 106 30 11
FOLIC ACID 99 86 31 379
CLONIDINE HCL 97 80 32 35
ATENOLOL 92 90 33 23
TRAMADOL HCL 90 70 34 16
FERROUS SULFATE 89 73 35 383
ESCITALOPRAM OXALATE 87 82 36 51
MIRTAZAPINE 86 77 37 82
NEXIUM 84 59 38 14
SERTRALINE HCL 81 81 39 26
NOVOLOG FLEXPEN 79 72 40 244
FEXOFENADINE HCL 79 63 40 272
TRAZODONE HCL 78 70 42 40
TAMSULOSIN HCL 78 66 42 32
OXYBUTYNIN CHLORIDE ER 77 64 44 154
SPIRONOLACTONE 77 52 44 85
HYDRALAZINE HCL 77 74 44 100
TAB-A-VITE 70 70 47 395
CLOPIDOGREL 68 68 48 28
HYDROCODONE-ACETAMINOPHEN 68 63 S3 48 3
CARBIDOPA-LEVODOPA 67 67 50 136
FERROUS GLUCONATE 66 66 10 51 402
FISH OIL 65 62 52 405
NIFEDIPINE ER 65 65 52 75
LANTUS SOLOSTAR 61 48 54 102
AMLODIPINE BESYLATE-BENAZEPRIL 57 57 55 41
GLIPIZIDE 56 33 56 62
LYRICA 56 56 56 71
ATORVASTATIN CALCIUM 55 46 58 13
PRECISION XTRA 55 48 10 58 428
LEVEMIR FLEXPEN 54 42 60 228
ALLOPURINOL 53 53 61 31
TIMOLOL MALEATE 52 52 62 373
LANTUS 52 49 62 50
NIASPAN 52 36 62 212
SENNA 51 38 65 378
FLUOXETINE HCL 51 42 65 63
FLUTICASONE PROPIONATE 51 43 65 39
GLIPIZIDE ER 50 50 68 110
ACCU-CHEK SAFE-T-PRO 50 47 10 68 435
LORATADINE 50 50 68 435
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 29, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.